KQB368
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for KQB368, covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies [Phase 1]